GlassScriptPhysician profile
Elias Joseph Arbid
NPI 1578561528
$18,575.13
in general payments reported to CMS, 2019-2025
34 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $836 · 2021: $5,464 · 2022: $9,963 · 2023: $1,109 · 2024: $516 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,864.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $12,435.04 | 2020-2024 | Auryon Laser System 100-120 Vac |
| Janssen Pharmaceuticals, INC | $1,720.38 | 2019-2024 | Xarelto |
| Endologix LLC | $624.33 | 2022-2023 | Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft |
| Philips North America LLC | $568.96 | 2020-2022 | |
| Boston Scientific Corporation | $415.35 | 2019-2025 | Peripheral Rotalink Plus, Avvigo Guidance System, Varithena Administration Pack |
| Organogenesis INC. | $352.68 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $346.46 | 2021-2024 | Rotarexs 6 F X 135 Cm, Venclose Maven Catheter |
| Cook Medical LLC | $252.02 | 2019-2025 | Rosen |
| Medtronic Vascular, INC. | $218.70 | 2019 | |
| Medtronic, INC. | $186.76 | 2022 | |
| Tactile Systems Technology INC | $167.75 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Shockwave Medical, INC | $151.67 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $117.02 | 2022-2023 | Jeti Peripheral Catheter |
| Getinge USA Sales, LLC | $106.86 | 2023 | Icast |
| Stability Biologics, LLC | $104.67 | 2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $89.75 | 2020-2022 | |
| Veryan Medical Incorporated | $89.15 | 2021 | |
| Molnlycke Health Care US, LLC | $84.33 | 2023 | Avance, Mepilex Ag, Mefix |
| Silk Road Medical, INC. | $79.83 | 2022 | |
| Smith+Nephew, INC. | $78.11 | 2022-2025 | Grafix, Stravix |
| Novo Nordisk INC | $60.85 | 2024 | |
| Venclose INC. | $51.82 | 2020 | |
| Biocompatibles, INC. | $47.01 | 2019 | |
| Cardiovascular Systems INC. | $31.01 | 2019-2022 | |
| Lemaitre Vascular, INC. | $26.88 | 2019-2023 | Artegraft Vascular Graft |
| Cvrx, INC. | $24.60 | 2022 | |
| Triad Life Sciences INC. | $22.91 | 2022 | |
| Artivion, INC. | $21.74 | 2020 | |
| Misonix INC | $21.67 | 2021 | |
| Inari Medical, INC. | $18.77 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ethicon US, LLC | $18.01 | 2024 | Surgiflo Hemostatic Matrix, Ethicon |
| W. L. Gore & Associates, INC. | $14.89 | 2019 | |
| Baudax Bio INC. | $13.53 | 2020 | |
| Biom'Up France Sas | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elias Arbid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.